What the scientists are saying...
A drug to “silence” cholesterol
A new “gene-silencing” drug has been found to reduce cholesterol levels by more than 50% in a clinical trial. Based on a technique known as RNA interference, the drug effectively “switches off” the gene responsible for elevating cholesterol levels. Delivered as an injection, the treatment, inclisiran, could be given twice yearly, with or without statins, depending on the patient’s need, to reduce their risk of heart attack or stroke. For the phase 2 trial, at Imperial College London, researchers gave 497 patients with high cholesterol either inclisiran, at varying doses, or a placebo. Most of the patients were already taking statins. A month after receiving a single treatment of inclisiran, patients’ levels of the harmful low-density lipoprotein (LDL) cholesterol were down by up to 51%. After six months, they were down by up to 42%. By contrast, patients in the control group were showing slightly elevated cholesterol levels. The results were even better for those who had two doses over three months: their LDL levels fell by as much as 53% after six months. Along with its effectiveness, the minimal dosing required sets the treatment apart: rather than having to take a pill daily, patients could visit their doctor twice a year for an injection. However, much more research is needed before it can come on the market.
Noses adapt to their climate
This story is from the April 01, 2017 edition of The Week UK.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the April 01, 2017 edition of The Week UK.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
Khalid Masood: The Making Of A Killer
Last Tuesday, Khalid Masood checked into the £59-a-night Preston Park Hotel in Brighton.
Europe's Faustian Bargain
A year ago, the EU and Turkey made a controversial deal to stem the flow of refugees into Europe. How has it panned out?
Carswell's Defection: Has UKIP Had It?
“Douglas Carswell was once the golden boy of UKIP,” said Tim Stanley in The Sunday Telegraph: “its first elected MP, its brightest intellect, its shot at respectability.”
The North Korea problem
Donald Trump warned this week that he was ready to tackle the nuclear threat from North Korea with or without help from China.
Europe's Last Colony
Spain has long been determined to regain sovereignty over “the Rock” at its southern tip, but Gibraltar remains stubbornly British.
His Only Crime Was Coming Home
As Western-backed forces push Islamic State out of Mosul, its militants are laying minefields in their wake – aimed not at soldiers but at ordinary people who have come back to rebuild their lives. Colin Freeman went on a tour of Iraq’s new killing fields
The Modest Dutch Designer Who Made Millions From Miffy
Dick Bruna, who has died aged 89, created one of the most instantly recognisable characters in children’s literature, said The New York Times: the sparsely drawn white rabbit known in English as Miffy.
Trump's conflict of interest: how will he deal with it?
Donald Trump ran, and won, on a promise to “drain the swamp” of Washington corruption, said Eugene Robinson in The Washington Post. But so far, he seems intent on deepening it. The president-elect owns or has stakes in around 500 companies, at least 111 of which do business overseas. This creates a massive and unprecedented conflict of interest. One of Trump’s biggest lenders, for example, is Germany’s Deutsche Bank, currently negotiating a multibillion-dollar settlement with the Justice Department over abuses that contributed to the 2008 market crash.
What the scientists are saying...
What the scientists are saying...
Cricket: Kohli hammers England
The end was “swift” and brutal, said Vic Marks in The Guardian. On the final morning of the fourth Test, in Mumbai, India needed less than half an hour to take England’s last four wickets. They thrashed the visitors by an innings and 36 runs to seal a 3-0 series victory, with the fifth Test still to be played.
